Dr Reddy's plans to drive growth through biosimilars, peptides, oncology, consumer healthcare and innovation while strengthening its core generics and API businesses.
Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...
"Where did my pet go?" If you have a pet, you've probably asked this question at least once. One moment they're playing ...
Analyst/Investor Day July 15, 2026 9:00 AM EDTCompany ParticipantsJan-Hendrik Mohr - Chairman of Management Board & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results